Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease

BACKGROUND: Although many therapeutic strategies for Alzheimer’s disease (AD) have been explored, these strategies are seldom used in the clinic. Therefore, AD therapeutic research is still urgently needed. One major challenge in the field of nanotherapeutics is to increase the selective delivery of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chunhong, Chu, Xiaoyang, Gong, Wei, Zheng, Jinpeng, Xie, Xiangyang, Wang, Yuli, Yang, Meiyan, Li, Zhiping, Gao, Chunsheng, Yang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222444/
https://www.ncbi.nlm.nih.gov/pubmed/32404183
http://dx.doi.org/10.1186/s12951-020-00626-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222444/
https://www.ncbi.nlm.nih.gov/pubmed/32404183
http://dx.doi.org/10.1186/s12951-020-00626-1

Ejemplares similares